Andrew Gross
Pain Medicine · Fort Myers, FLNPI 1942341334
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $690 and has fallen 60.1% since, to $275 in 2023.
Across 167 payments — averaging $16.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$580
- Biodelivery Sciences International, Inc.$414
- Scilex Pharmaceuticals Inc.$342
- Nevro Corp.$333
- Amgen$320
- Collegium Pharmaceutical, Inc.$161
- plus $608 from 14 others
What the payments were for
- Food & beverage$2,748100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 35 | $580 |
| Biodelivery Sciences International, Inc. | 50 | $414 |
| Scilex Pharmaceuticals Inc. | 16 | $342 |
| Nevro Corp. | 10 | $333 |
| Amgen(2 entities) | 20 | $320 |
| Collegium Pharmaceutical, Inc. | 7 | $161 |
| Stimwave Technologies Incorporated | 3 | $113 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $89 |
| Medtronic | 4 | $77 |
| Boston Scientific | 4 | $66 |
| Triad Life Sciences Inc. | 1 | $54 |
| Biohaven Pharmaceuticals, Inc. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Si-bone, Inc. | 1 | $29 |
| Johnson & Johnson | 1 | $25 |
| Daiichi Sankyo Inc. | 2 | $24 |
| Pacira Therapeutics, Inc. | 1 | $20 |
| Pfizer | 1 | $17 |
| Novartis | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,757 in reported general payments places this provider in the 55th percentile of 596 pain medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 24 | $3,782 |
| Morphine Sulfate ErMorphine Sulfate | 24 | $1,231 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 12 | $714 |
| Pantoprazole Sodium | 13 | $672 |
| Divalproex Sodium | 11 | $645 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 11 | $581 |
| Gabapentin | 18 | $497 |
| Oxycodone Hcl | 13 | $243 |
| Levothyroxine Sodium | 22 | $209 |
| Famotidine | 12 | $194 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Fort Myers
- Jonathan DaitchFort Myers$39K
- Velimir MicovicFort Myers$19K
- Jeffrey GudinMiami$356K
- Joseph PergolizziNaples$333K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
- Mark-Friedrich HurdleJacksonville$140K
- Rodolfo GariTampa$120K
- Stephen PylesOcala$115K
- Orlando FloreteJacksonville$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.